# Treatment With Apremilast in Patients With Psoriatic Arthritis

> **NCT02558361** · PHASE4 · WITHDRAWN · sponsor: **University of South Florida**

## Conditions studied

- Psoriatic Arthritis

## Interventions

- **DRUG:** Treatment with Apremilast

## Key facts

- **NCT ID:** NCT02558361
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-04
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** FDA approved synovial biopsy device unavailable
- **Last updated:** 2016-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02558361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02558361, "Treatment With Apremilast in Patients With Psoriatic Arthritis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02558361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*